Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial - The Lancet Neurology
Pompe Disease Types | Pompe Disease News
Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease: Molecular Therapy Methods & Clinical Development